Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
<Research>JPM Hikes TPs for CN Life Insurance Stocks; Top Pick CHINA LIFE
Recommend 22 Positive 32 Negative 12 |
||||
|
||||
|
JPMorgan has released a report upgrading the rating for China's life insurance industry ahead of the release of insurers' 1H25 results. The broker has upgraded CHINA LIFE (02628.HK) and NCI (01336.HK) from Underweight to Overweight, while China Life (601628.SH) and NCI (601336.SH) have been upgraded to Neutral only. This repositioning has reflected the broker's overall positive outlook on H-shares, which currently have a 33% discount compared to A-shares. The three main drivers of this view included: accelerated product portfolio optimization enhancing profitability; regulatory easing and improved solvency capital measures boosting profit margins; and strong stock market performance supporting continuous earnings forecast upgrades. They outweighed previous concerns about temporary dividend risks due to A-share volatility and economic capital pressure under low yields. The average P/E ratio for H-shares in the life insurance sector for FY26 is 7 times with a 4% dividend yield, appearing attractive given low investor positioning. Overall, JPMorgan expects larger upward potential before the release of their 1H25 results. JPMorgan anticipates opportunities for earnings upgrades and sustained dividends from the 1H25 results. Its pecking order was: CHINA LIFE's H-shares, PING AN (02318.HK), NCI's H-shares, PICC P&C (02328.HK), PICC GROUP (01339.HK), and CPIC (02601.HK). AAStocks Financial News |
||||
Copied to Clipboard
 |
||||
